Companies
Electrochaea
operates commercial-scale biological methanation plants in Denmark and Switzerland; its patented thermophilic Methanothermobacter catalyst converts CO2 and green hydrogen into pipeline-quality biomethane at high selectivity.
- Country
- Germany
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| biofuels-bioenergy | ✓ | ✓ | ✓ |
Regulatorsepareachnea
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | failed in spring 2026, leading to insolvency in April 2026 | deutsche-startup-zeitung.de · in.investing.com · eqs-news.com |
| Capacity | Demonstrated at 1 MWe scale; planned commercial-scale plants designed for 10 MWe and up to 100+ MWe capacity | bioreco2ver.eu · cordis.europa.eu · electrochaea.com |
| Certification | e-methane produced is compliant with and independently certifiable under various regulations and mandates | electrochaea.com |
| Production site | Demonstration plants in Denmark, Switzerland, Germany, and the United States | bioreco2ver.eu · in.investing.com · electrochaea.com |
| Headcount | 33 employees (as of October 2024) | cordis.europa.eu |
| Revenue | Loss-making since inception; no cost-covering industrial-scale production achieved | in.investing.com · eqs-news.com |
Independent sources: bioreco2ver.eu · cordis.europa.eu · deutsche-startup-zeitung.de · eqs-news.com · in.investing.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Power-to-X with biological step | biofuels-bioenergy | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.